This inventor holds 1 USPTO granted patent. Top assignee: China Medical University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations by Chiz-Tzung Chang in Atherosclerotic Vascular Disease Diagnosis
Introduction
Chiz-Tzung Chang is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in assessing the risk of atherosclerotic vascular disease (ASVD). His innovative approach has the potential to enhance early detection and intervention strategies for this serious health condition.
Latest Patents
Chiz-Tzung Chang holds a patent for a method designed to diagnose whether a subject is at high risk for developing atherosclerotic vascular disease. The patent outlines a systematic approach that includes providing a specimen from the subject, analyzing it using gradient gel electrophoresis, and determining the risk based on the analysis results. This method represents a significant advancement in the diagnostic capabilities for ASVD.
Career Highlights
Chang is affiliated with China Medical University, where he applies his expertise in medical research and innovation. His work focuses on developing diagnostic methods that can lead to better patient outcomes. With a patent count of 1 patent, he exemplifies the impact that a single innovative idea can have in the medical field.
Collaborations
Chiz-Tzung Chang collaborates with esteemed colleagues such as Chao-Jung Chen and Chao-Yuh Yang. Their combined efforts contribute to the advancement of medical research and the development of effective diagnostic tools.
Conclusion
Chiz-Tzung Chang's contributions to the diagnosis of atherosclerotic vascular disease highlight the importance of innovation in healthcare. His patented method not only showcases his ingenuity but also emphasizes the potential for improved health outcomes through early detection.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
